Skip to main navigation Skip to search Skip to main content

Structural basis of p21(H-ras) molecular switch inhibition by a neutralizing antibody

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

The ras oncogene product p21 functions as a molecular switch in the early section of the signal transduction pathway that is involved in cell growth and differentiation. When the protein is in its GTP-complexed form it is active in signal transduction, whereas it is inactive in its GDP-complexed form. The transforming activity of p21(ras) is neutralized by the mouse monoclonal antibody Y13-259, possibly by preventing GDP-GTP exchange. A molecular model of the variable fragment of Y13-259 has been derived using a knowledge-based prediction approach and computer-assisted modeling techniques. An analysis of this model while complexed with p21(ras)/(GDP) indicated that the two molecular switch regions are constrained by complex formation. Antibody binding inhibits GDP-GTP exchange through a mechanism of steric hindrance. Having identified necessary bound sites for inhibition, and explored their electrostatic properties,it should be possible to proceed with the design of antibody mimics as therapeutic agents in cancer control.

Original languageEnglish
Pages (from-to)42-50
Number of pages9
JournalJournal of Molecular Graphics
Volume14
Issue number1
DOIs
Publication statusPublished - 19 Jan 1996

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-cancer drug design
  • Homology modeling
  • Molecular switch
  • Monoclonal antibody
  • Oncoprotein

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry

Fingerprint

Dive into the research topics of 'Structural basis of p21(H-ras) molecular switch inhibition by a neutralizing antibody'. Together they form a unique fingerprint.

Cite this